Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
29.08
+0.57 (2.00%)
Sep 29, 2026, 9:53 AM EDT - Market open

Adaptive Biotechnologies Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Buy
Initiates
$35
BuyInitiates$35+20.36%Sep 29, 2026
BTIG
BTIG
Buy
Reiterates
$25 → $34
BuyReiterates$25 → $34+16.92%Sep 22, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
n/a
BuyMaintainsn/an/aSep 18, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$28
BuyMaintains$28-5.43%Aug 24, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$25 → $27
BuyMaintains$25 → $27-7.15%Jul 30, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$20 → $22
HoldMaintains$20 → $22-24.35%Jul 30, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$22 → $25
BuyReiterates$22 → $25-14.03%Jul 30, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJul 30, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.